|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: INSIG1 |
Gene summary for INSIG1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | INSIG1 | Gene ID | 3638 |
| Gene name | insulin induced gene 1 | |
| Gene Alias | CL6 | |
| Cytomap | 7q36.3 | |
| Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | A4D2M9 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 3638 | INSIG1 | LZE2T | Human | Esophagus | ESCC | 2.88e-04 | 7.22e-01 | 0.082 |
| 3638 | INSIG1 | LZE4T | Human | Esophagus | ESCC | 2.76e-03 | 5.46e-01 | 0.0811 |
| 3638 | INSIG1 | LZE8T | Human | Esophagus | ESCC | 7.53e-03 | -1.77e-01 | 0.067 |
| 3638 | INSIG1 | LZE20T | Human | Esophagus | ESCC | 6.94e-07 | 3.14e-02 | 0.0662 |
| 3638 | INSIG1 | LZE24T | Human | Esophagus | ESCC | 2.17e-05 | 6.54e-01 | 0.0596 |
| 3638 | INSIG1 | LZE21T | Human | Esophagus | ESCC | 1.74e-03 | 8.17e-01 | 0.0655 |
| 3638 | INSIG1 | LZE6T | Human | Esophagus | ESCC | 7.89e-04 | -2.89e-01 | 0.0845 |
| 3638 | INSIG1 | P2T-E | Human | Esophagus | ESCC | 8.61e-04 | 2.69e-01 | 0.1177 |
| 3638 | INSIG1 | P4T-E | Human | Esophagus | ESCC | 1.44e-34 | 1.94e+00 | 0.1323 |
| 3638 | INSIG1 | P5T-E | Human | Esophagus | ESCC | 5.11e-34 | 1.71e+00 | 0.1327 |
| 3638 | INSIG1 | P8T-E | Human | Esophagus | ESCC | 8.58e-06 | 3.81e-01 | 0.0889 |
| 3638 | INSIG1 | P9T-E | Human | Esophagus | ESCC | 8.46e-10 | 7.51e-01 | 0.1131 |
| 3638 | INSIG1 | P10T-E | Human | Esophagus | ESCC | 1.25e-40 | 1.86e+00 | 0.116 |
| 3638 | INSIG1 | P11T-E | Human | Esophagus | ESCC | 1.23e-04 | 9.38e-01 | 0.1426 |
| 3638 | INSIG1 | P12T-E | Human | Esophagus | ESCC | 3.20e-07 | 3.15e-01 | 0.1122 |
| 3638 | INSIG1 | P15T-E | Human | Esophagus | ESCC | 3.38e-27 | 1.46e+00 | 0.1149 |
| 3638 | INSIG1 | P17T-E | Human | Esophagus | ESCC | 1.27e-02 | -1.90e-02 | 0.1278 |
| 3638 | INSIG1 | P20T-E | Human | Esophagus | ESCC | 9.48e-16 | 8.70e-01 | 0.1124 |
| 3638 | INSIG1 | P21T-E | Human | Esophagus | ESCC | 6.17e-19 | 1.43e+00 | 0.1617 |
| 3638 | INSIG1 | P22T-E | Human | Esophagus | ESCC | 4.16e-23 | 9.29e-01 | 0.1236 |
| Page: 1 2 3 4 5 6 7 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| GC |  | CAG: Chronic atrophic gastritis |
| CAG with IM: Chronic atrophic gastritis with intestinal metaplasia | ||
| CSG: Chronic superficial gastritis | ||
| GC: Gastric cancer | ||
| SIM: Severe intestinal metaplasia | ||
| WIM: Wild intestinal metaplasia | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00512352 | Stomach | CSG | maintenance of location | 37/1034 | 327/18723 | 2.84e-05 | 8.08e-04 | 37 |
| GO:005165121 | Stomach | CSG | maintenance of location in cell | 27/1034 | 214/18723 | 5.28e-05 | 1.35e-03 | 27 |
| GO:00451852 | Stomach | CSG | maintenance of protein location | 14/1034 | 94/18723 | 6.28e-04 | 9.02e-03 | 14 |
| GO:00066332 | Stomach | CSG | fatty acid biosynthetic process | 19/1034 | 163/18723 | 1.68e-03 | 1.85e-02 | 19 |
| GO:00463942 | Stomach | CSG | carboxylic acid biosynthetic process | 30/1034 | 314/18723 | 2.52e-03 | 2.46e-02 | 30 |
| GO:004343421 | Stomach | CSG | response to peptide hormone | 37/1034 | 414/18723 | 2.75e-03 | 2.62e-02 | 37 |
| GO:00160532 | Stomach | CSG | organic acid biosynthetic process | 30/1034 | 316/18723 | 2.77e-03 | 2.63e-02 | 30 |
| GO:006201221 | Stomach | CSG | regulation of small molecule metabolic process | 30/1034 | 334/18723 | 6.13e-03 | 4.77e-02 | 30 |
| GO:005165131 | Stomach | CAG | maintenance of location in cell | 18/552 | 214/18723 | 6.79e-05 | 1.89e-03 | 18 |
| GO:00512353 | Stomach | CAG | maintenance of location | 23/552 | 327/18723 | 1.15e-04 | 2.85e-03 | 23 |
| GO:00451853 | Stomach | CAG | maintenance of protein location | 10/552 | 94/18723 | 4.49e-04 | 7.68e-03 | 10 |
| GO:00325073 | Stomach | CAG | maintenance of protein location in cell | 8/552 | 65/18723 | 6.25e-04 | 1.02e-02 | 8 |
| GO:0072595 | Stomach | CAG | maintenance of protein localization in organelle | 6/552 | 42/18723 | 1.36e-03 | 1.75e-02 | 6 |
| GO:00709723 | Stomach | CAG | protein localization to endoplasmic reticulum | 8/552 | 74/18723 | 1.48e-03 | 1.83e-02 | 8 |
| GO:00069006 | Stomach | CAG | vesicle budding from membrane | 7/552 | 61/18723 | 2.05e-03 | 2.32e-02 | 7 |
| GO:19038284 | Stomach | CAG | negative regulation of cellular protein localization | 10/552 | 117/18723 | 2.43e-03 | 2.61e-02 | 10 |
| GO:1904950 | Stomach | CAG | negative regulation of establishment of protein localization | 10/552 | 131/18723 | 5.46e-03 | 4.55e-02 | 10 |
| GO:00512354 | Stomach | WIM | maintenance of location | 20/426 | 327/18723 | 6.52e-05 | 1.93e-03 | 20 |
| GO:00451854 | Stomach | WIM | maintenance of protein location | 9/426 | 94/18723 | 2.90e-04 | 6.11e-03 | 9 |
| GO:005165141 | Stomach | WIM | maintenance of location in cell | 14/426 | 214/18723 | 4.08e-04 | 7.78e-03 | 14 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| INSIG1 | SNV | Missense_Mutation | novel | c.698N>A | p.Val233Asp | p.V233D | O15503 | protein_coding | deleterious(0) | probably_damaging(0.969) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| INSIG1 | deletion | In_Frame_Del | c.776_778delTGG | p.Val259del | p.V259del | O15503 | protein_coding | TCGA-A8-A07W-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | exemestane | SD | |||
| INSIG1 | SNV | Missense_Mutation | c.108G>C | p.Glu36Asp | p.E36D | O15503 | protein_coding | tolerated_low_confidence(0.18) | benign(0) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
| INSIG1 | SNV | Missense_Mutation | novel | c.349N>A | p.Glu117Lys | p.E117K | O15503 | protein_coding | tolerated(0.1) | probably_damaging(0.996) | TCGA-VS-A9V0-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
| INSIG1 | SNV | Missense_Mutation | rs780785188 | c.769N>A | p.Val257Ile | p.V257I | O15503 | protein_coding | tolerated(0.38) | probably_damaging(0.995) | TCGA-AZ-4313-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| INSIG1 | deletion | In_Frame_Del | novel | c.276_278delNNN | p.Phe92_Ser93delinsLeu | p.F92_S93delinsL | O15503 | protein_coding | TCGA-AA-3845-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | ||
| INSIG1 | SNV | Missense_Mutation | novel | c.737N>A | p.Ser246Tyr | p.S246Y | O15503 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AJ-A5DW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| INSIG1 | SNV | Missense_Mutation | novel | c.757T>G | p.Phe253Val | p.F253V | O15503 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
| INSIG1 | SNV | Missense_Mutation | novel | c.409N>A | p.Ala137Thr | p.A137T | O15503 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| INSIG1 | SNV | Missense_Mutation | novel | c.293N>G | p.Leu98Arg | p.L98R | O15503 | protein_coding | deleterious(0) | probably_damaging(0.955) | TCGA-EY-A1GI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |